DAFTAR ISI

Halaman
LEMBAR PERSETUJUAN ......................................................................................... ii
KATA PENGANTAR ................................................................................................. iii
DAFTAR ISI ................................................................................................................ iv
DAFTAR TABEL ......................................................................................................... v
DAFTAR GAMBAR ................................................................................................... vi
BAB I PENYAJIAN KASUS ...................................................................................... 1
1.1. Latar Belakang ............................................................................................. 1
1.2. Anamnesis ..................................................................................................... 1
1.3. Pemeriksaan Fisik ........................................................................................ 2
1.4. Pemeriksaan Penunjang ............................................................................... 4
1.5. Resume Medis .............................................................................................. 7
1.6. Diagnosis ..................................................................................................... 7
1.7. Tata Laksana ................................................................................................ 8
1.8. Prognosis ...................................................................................................... 9
BAB II PEMBAHASAN .......................................................................................... . 10
2.1. Nyeri Dada ..................................................................................................... 10
2.2. Definisi ACS .................................................................................................. 12
2.3. Patofisiologi ................................................................................................... 13
2.4. Diagnosis ....................................................................................................... 14
2.5. Stratifikasi Resiko .......................................................................................... 18
2.6. Manajemen Terapi ........................................................................................ 25
BAB III KESIMPULAN ............................................................................................. 26
DAFTAR PUSTAKA ................................................................................................. 27

iv
 DAFTAR TABEL
Halaman
Tabel 1. Skor TIMI untuk UAP dan NSTEMI ........................................................... 19
Tabel 2. Strafikasi risiko berdasarkan skor TIMI ....................................................... 19
Tabel 3. Skor GRACE ............................................................................................... 20
Tabel 4. Stratifikasi risiko kematian berdasarkan skor GRACE ............................... 21
Tabel 5. Skor GRACE pada pasien Tn. S .................................................................. 21
Tabel 6. Mortalitas 30 hari berdasarkan kelas killip .................................................. 22
Tabel 7. Skor risiko perdarahan CRUSADE ............................................................. 23
Tabel 8. Stratifikasi risiko berdasarkan skor CRUSADE .......................................... 24
Tabel 9. Skor risiko perdarahan CRUSADE pada Tn. S ........................................... 25
Tabel 10. Terapi suportif pada ACS NSTEMI7 ......................................................... 26
Tabel 11. Jenis dan dosis penyekat beta untuk terapi IMA ....................................... 27
Tabel 12. Jenis dan dosis nitrat untuk terapi IMA ..................................................... 28
Tabel 13. Jenis dan dosis penghambat kanal kalsium untuk terapi IMA .................. 29
Tabel 14. Jenis dan dosis antiplatelet untuk terapi IMA ............................................ 30
Tabel 15. Jenis dan dosis antikoagulan untuk IMA ................................................... 31
Tabel 16. Jenis dan dosis inhibitor ACE untuk IMA ................................................. 33
Tabel 17. Jenis dan dosis statin intensitas tinggi8 ...................................................... 33
Tabel 18. Kriteria risiko untuk menentukan strategi invasif pada ACS-NSTEMI .... 34
7
Tabel 19. Waktu strategi invasif berdasarkan risiko individu .................................. 35

v
 DAFTAR GAMBAR
Halaman
Gambar 1. Inversi Gelombang T ................................................................................ 16
Gambar 2. Depresi segmen ST ................................................................................... 16
Gambar 3. Waktu rilisnya berbagai biomarker setelah infark miokard ...................... 17
Gambar 4. Perbedaan Non-cardiac, UA, ACS NSTEMI dan STEMI ........................... 18
Gambar 5. Risiko perdarahan mayor berdasarkan skor perdarahan CRUSADE ....... 24
Gambar 6. Antitrombosis untuk ACS NSTEMI ......................................................... 32
Gambar 7. Pemilihan strategi terapi dan waktu berdasarkan stratifikasi risiko ACS-
NSTEMI........................................................................................................................ 36

vi